By Helgi Library - December 4, 2020
Lenzing Biocel Paskov employed 407 employees in 2019, up 3.56% compared to the previous year. Historically, between 200...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Total sales reached CZK ...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov's total assets reached CZK 7,358 mil at the end of 2019, down 0.049% compared to the previous year. ...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Cash Flow |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil with revenues of CZK 5,285 mil in 2019, down by 21.6% and up by 0.683%, respectively, compared to the previous year. This translates into a net margin of 21.0%. Historically, between 2007 and 2019...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Historically, between 2007 and 2019, the company's net profit reached a high of CZK 1,621 mil in 2017 and a low of CZK -99.0 mil in 2012. The resul...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov's net debt stood at CZK -1,587 mil and accounted for -25.2% of equity at the end of 2019. The ratio is down 6.88 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 105% in 2013 and ...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov invested a total of CZK 260 mil in 2019, up 6.11% compared to the previous year. Historically, between 2008 - 2019, the company's investments stood at a high of CZK 958 mil in 2012 and a low of CZK -798 mil in 2015. ...
Biocel Paskov a.s. is a Czech Republic-based manufacturer of viscose pulp for the textile industry in Austria, the Netherlands, Estonia, and internationally. The Company was founded in 2001 and is based in Paskov, Czech Republic. Biocel Paskov a.s. operates as a subsidiary of Lenzing Aktiengesellschaft.
Lenzing Biocel Paskov has been growing its sales by 0.097% a year on average in the last 5 years. EBITDA has grown on average by 6.46% a year during that time to total of CZK 1,938 mil in 2019, or 36.7% of sales. That’s compared to 37.8% average margin seen in last five years.
The company netted CZK 1,111 mil in 2019 implying ROE of 17.7% and ROCE of 19.9%. Again, the average figures were 24.4% and 22.4%, respectively when looking at the previous 5 years.
Lenzing Biocel Paskov’s net debt amounted to CZK -1,587 mil at the end of 2019, or -25.2% of equity. When compared to EBITDA, net debt was -0.819x, down when compared to average of -0.380x seen in the last 5 years.
Helgi Library 
